Janus kinase (JAK) inhibitors, biologics and more—Dr. Laura Coates discussed the management of PsA, providing insights into the current research and when clinicians may want to consider prescribing specific medications.
Latest News
FDA Approves Ustekinumab-stba for All Forms & Dosages as Its Reference Product
Ustekinumab-stba (Steqeyma) now has FDA approval for all forms and dosages of its reference product, ustekinumab (Stelara), including a subcutaneous injection to treat pediatric patients with plaque psoriasis or psoriatic arthritis.
B Original
Experts discussed how aspects of the immune system other than B cells play a role in lupus, including mitochondria in red blood cells, proteins present in urine and more.
Physician Editor Bharat Kumar, MD, & The Rheumatologist Recognized for Excellence
The American College of Rheumatology and Wiley are happy to announce that The Rheumatologist has received two APEX Awards of Excellence this year for content…
Doctoring Differently, Part 2
In part 2 of Dr. Sam Shapiro’s journey, learn how she connected with the rheumatology community to change her career and found a better way to embrace her passions for clinical rheumatology, education and helping patients.
Past ACR President Named a PANLAR Master
This spring, PANLAR designated Mary K. Crow, MD, a Master of Rheumatology. She was honored for her career in research and work extending research opportunities to investigators in Latin America.
